UniQure: 2Q Earnings Snapshot
AMSTERDAM (AP) _ UniQure NV (QURE) on Monday reported a loss of $31.4 million in its second quarter.
The Amsterdam-based company said it had a loss of 83 cents per share.
The results did not meet Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 75 cents per share.
The human gene therapy company posted revenue of $2.5 million in the period, surpassing Street forecasts. Five analysts surveyed by Zacks expected $1.5 million.
UniQure shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.